Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

XLV vs FACDX overlap: 45% of top holdings shared

Bottom line

How much do XLV and FACDX overlap?

45% of their top holdings overlap by weight. 10 securities appear in both funds' top 25, making up 58.4% of XLV's assets and 38.1% of FACDX's. They share a meaningful core but differ in the rest of the portfolio.

FACDX holds far more positions (154 vs 65), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

XLVFACDX
Weight overlap (top 25)45%
Shared holdings10
Weight in shared holdings58.4%38.1%
Total positions65154
Expense ratio0.08%0.96%
Holdings as ofJun 30, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Holdings XLV and FACDX have in common

Holding% of XLV% of FACDXOverlap
Eli Lilly & Co16.51%7.66%7.66%
Johnson & Johnson10.64%3.78%3.78%
AbbVie Inc7.74%3.62%3.62%
UnitedHealth Group Inc6.57%4.17%4.17%
Merck & Co Inc5.52%2.09%2.09%
Thermo Fisher Scientific Inc3.24%6.31%3.24%
Gilead Sciences Inc2.73%1.25%1.25%
CVS Health Corp2.30%1.29%1.29%
Danaher Corp2.09%6.75%2.09%
Boston Scientific Corp1.10%1.23%1.10%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in XLV

  1. Amgen Inc — 3.40%
  2. Abbott Laboratories — 2.75%
  3. Intuitive Surgical Inc — 2.45%
  4. Pfizer Inc — 2.39%
  5. Vertex Pharmaceuticals Inc — 2.19%
  6. Bristol-Myers Squibb Co — 2.05%
  7. Stryker Corp — 1.89%
  8. Medtronic PLC — 1.75%
  9. McKesson Corp — 1.58%
  10. Elevance Health Inc — 1.46%
  11. Cigna Group/The — 1.27%
  12. Regeneron Pharmaceuticals Inc — 1.08%
  13. HCA Healthcare Inc — 1.05%
  14. Cardinal Health Inc — 0.97%
  15. Cencora Inc — 0.96%

Only in FACDX

  1. Fidelity Revere Street Trust — 2.54%
  2. Argenx Se — 2.09%
  3. West Pharmaceutical Svcs Inc — 2.06%
  4. Ascendis Pharma A/s — 1.95%
  5. Alnylam Pharmaceuticals Inc — 1.78%
  6. Agilent Technologies Inc — 1.75%
  7. Viatris Inc — 1.67%
  8. Natera Inc — 1.65%
  9. Guardant Health Inc — 1.48%
  10. 10x Genomics Inc — 1.45%
  11. Revolution Medicines Inc — 1.44%
  12. Waters Corp — 1.43%
  13. Oruka Therapeutics Inc — 1.32%
  14. Ucb Sa — 1.32%
  15. Repligen Corp — 1.22%

Asset mix

Asset typeXLVFACDX
Stocks99.7%97.7%
Cash & short-term funds0.3%2.8%
Preferred stock—2.1%
Bonds—0.2%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Country mix

CountryXLVFACDX
US97.9%88.0%
NL—2.9%
GB—2.6%
IE2.1%1.0%
DK—2.0%
BE—1.3%
KY—1.3%
BM—1.0%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do XLV and FACDX overlap?
About 45% by weight. 10 securities appear in both funds' top 25 holdings; they make up 58.4% of XLV's assets and 38.1% of FACDX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do XLV and FACDX have in common?
The largest shared holdings are Eli Lilly & Co, UnitedHealth Group Inc, Johnson & Johnson, AbbVie Inc, Thermo Fisher Scientific Inc.
Should I own both XLV and FACDX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, XLV or FACDX?
FACDX is broader, with 154 positions versus 65 for XLV. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.